Congress scrambles for a new funding deal, a report details the financial impacts of a mandatory bundled payment model, and a woman receives a genetically modified pig kidney transplant.

Congress negotiates its year-end healthcare package, Dreamers lose access to ACA exchanges, and Elevance reverses its controversial anesthesia policy.

It has been an incredibly busy and exciting year for our Strategy & Business Transformation practice at Kaufman Hall. In 2024, we observed hospitals and health systems take steps to reinvigorate their strategic efforts amid a stabilizing, but still challenging, outlook.

The future will favor payers that adapt to changing market circumstances with agency and velocity. Payers will need to make tough choices.

With extension of the 2017 tax cuts identified as a key priority for the incoming Trump administration, offsetting expense actions will be needed to avoid increasing the federal deficit. Hospital leaders should be prepared for potential cuts to both the Medicaid program and the enhanced ACA subsidies enacted in 2021.

CMS proposes adding weight-loss drugs to Medicare coverage, Trump nominates more healthcare positions, and a study tracks widespread pharmacy closures.

A growth strategy focused on access, accretive opportunities, and ambulatory represents a new “Triple A” for hospitals and health systems.

Trump picks his healthcare cabinet nominees, PBMs sue the FTC over its insulin case, and controlled substance telehealth flexibilities are extended yet again.

Recent efforts to contemporize primary care have proven that the best intentions, the smartest ideas, and a lot of money are no guarantee of commercial success. Corporate America has found primary care to be a confounding and, so far, unsuccessful business model.

DOJ sues to block UHG-Amedisys deal, Cigna quashes Humana merger talks, and Johnson & Johnson sues to revive its 340B rebate program.

As health systems enter a period of relative stabilization following the pandemic and its inflationary aftermath, many leaders are rethinking their organization’s enterprise strategy.

CMS finalizes the 2025 OPPS rule, an appeals court rules reverses a No Surprises Act decision, and MACPAC calls for more Medicaid payment oversight.